- Home
- TWG vs BIAF Comparison
TWG vs BIAF Comparison
Compare TWG & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWG
- BIAF
- Stock Information
- Founded
- TWG 2009
- BIAF 2014
- Country
- TWG Hong Kong
- BIAF United States
- Employees
- TWG 12
- BIAF N/A
- Industry
- TWG
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- TWG
- BIAF Health Care
- Exchange
- TWG NYSE
- BIAF Nasdaq
- Market Cap
- TWG 11.1M
- BIAF 14.5M
- IPO Year
- TWG 2024
- BIAF 2022
- Fundamental
- Price
- TWG $0.21
- BIAF $1.04
- Analyst Decision
- TWG
- BIAF Strong Buy
- Analyst Count
- TWG 0
- BIAF 1
- Target Price
- TWG N/A
- BIAF $6.00
- AVG Volume (30 Days)
- TWG 1.7M
- BIAF 131.4K
- Earning Date
- TWG 02-15-2025
- BIAF 11-14-2024
- Dividend Yield
- TWG N/A
- BIAF N/A
- EPS Growth
- TWG 27.13
- BIAF N/A
- EPS
- TWG 0.09
- BIAF N/A
- Revenue
- TWG $16,943,287.00
- BIAF $9,367,785.00
- Revenue This Year
- TWG N/A
- BIAF $285.51
- Revenue Next Year
- TWG N/A
- BIAF $20.05
- P/E Ratio
- TWG $2.44
- BIAF N/A
- Revenue Growth
- TWG 99.03
- BIAF 2813.87
- 52 Week Low
- TWG $0.17
- BIAF $0.83
- 52 Week High
- TWG $13.50
- BIAF $3.62
- Technical
- Relative Strength Index (RSI)
- TWG N/A
- BIAF 42.08
- Support Level
- TWG N/A
- BIAF $0.83
- Resistance Level
- TWG N/A
- BIAF $1.04
- Average True Range (ATR)
- TWG 0.00
- BIAF 0.11
- MACD
- TWG 0.00
- BIAF 0.01
- Stochastic Oscillator
- TWG 0.00
- BIAF 52.38
About TWG TOP WEALTH GROUP HLDG LTD
Top Wealth Group Holding Ltd is as supplier of caviar and offer caviar-based gourmet products. It is specialized in supplying high quality sturgeons caviar.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.